Figure 3From: Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors Mean cost for OA treatment according to different scenarios and to each adverse event at the Instituto Mexicano del Seguro Social. GI, gastrointestinal.Back to article page